6th Annual Immuno-Oncology 360°

Start

Wed, 26 Feb 2020, 09:00

End

Fri, 28 Feb 2020, 17:00

WebSite

https://iii.hm/yc3

Venue:

Find The Conference Forum on Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 6th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

Access to KOLs driving the science
Partnership opportunities with all stakeholders in Immuno-Oncology
Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

Key Topic Areas for 2020

Discovery & Preclinical Science
Translational Science & Biomarkers
Bispecifics
IO Combinations
Cell and Gene Therapy
AI & Machine Learning
IO Imaging Aspects
Clinical Data Developments
Clinical Operations
Emerging Technologies
Business Aspects

Immuno-Oncology 360° reports on the most current data and rapid advancements to help IO stakeholders:

Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof
Partner to expand technology platforms to develop therapeutics at an accelerated rate
Receive the latest pre-clinical, translational and clinical data from academia and industry
Create and prioritize strategies targeted toward specific tumor types
Identify and gain a greater understanding of what assets are available for potential combinations
Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
Obtain coverage on a wide range of emerging technologies